|
?:authorAffiliation
|
-
[\'Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA.\', \'Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA.\', \'Department of Pathology, University of Texas Medical Branch, Galveston, TX, USA.\', \'Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, Singapore.\', \'Department of Internal Medicine, University of Texas Medical Branch, Galveston, TX, USA.\', \'Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, TX, USA.\', \'Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA. xuxie@UTMB.edu.\', \'Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA. peshi@UTMB.edu.\', \'Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, TX, USA. peshi@UTMB.edu.\', \'Sealy Institute for Vaccine Sciences, University of Texas Medical Branch, Galveston, TX, USA. peshi@UTMB.edu.\', \'Sealy Center for Structural Biology & Molecular Biophysics, University of Texas Medical Branch, Galveston, TX, USA. peshi@UTMB.edu.\', \'Institute for Translational Science, University of Texas Medical Branch, Galveston, TX, USA. peshi@UTMB.edu.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}